Key result
Dose adjustment during dofetilide loading predicted unsuccessful initiation (OR 0.19; 95% CI 0.12-0.31; p<0.001); a reinforcement learning model predicted dosing decisions with 96.1% accuracy.
Why the study?
Although a recommended dose management algorithm for dofetilide exists, there is a range of real-world approaches to dosing the medication during initiation.
Can a reinforcement learning algorithm accurately predict dosing decisions during dofetilide initiation?
Observational (n=354)
Yes
Can a reinforcement learning algorithm accurately predict dosing decisions during dofetilide initiation?
Odds Ratio: 0.19 (95% CI 0.12–0.31)
p-value: p=<0.001
A reinforcement learning model accurately predicted dofetilide dosing decisions, suggesting its potential utility as a clinical decision aid during initiation.
May aid dofetilide dosing decisions; hypothesis-generating and requires prospective validation before adoption.
BACKGROUND: Initiation of the antiarrhythmic medication dofetilide requires an FDA-mandated 3 days of telemetry monitoring due to heightened risk of toxicity within this time period. Although a recommended dose management algorithm for dofetilide exists, there is a range of real-world approaches to dosing the medication. METHODS AND RESULTS: In this multicenter investigation, clinical data from the Antiarrhythmic Drug Genetic (AADGEN) study was examined for 354 patients undergoing dofetilide initiation. Univariate logistic regression identified a starting dofetilide dose of 500 mcg (OR 5.0, 95%CI 2.5-10.0, p<0.001) and sinus rhythm at the start of dofetilide loading (OR 2.8, 95%CI 1.8-4.2, p<0.001) as strong positive predictors of successful loading. Any dose-adjustment during loading (OR 0.19, 95%CI 0.12-0.31, p<0.001) and a history coronary artery disease (OR 0.33, 95%CI 0.19-0.59, p<0.001) were strong negative predictors of successful dofetilide loading. Based on the observation that any dose adjustment was a significant negative predictor of successful initiation, we applied multiple supervised approaches to attempt to predict the dose adjustment decision, but none of these approaches identified dose adjustments better than a probabilistic guess. Principal component analysis and cluster analysis identified 8 clusters as a reasonable data reduction method. These 8 clusters were then used to define patient states in a tabular reinforcement learning model trained on 80% of dosing decisions. Testing of this model on the remaining 20% of dosing decisions revealed good accuracy of the reinforcement learning model, with only 16/410 (3.9%) instances of disagreement. CONCLUSIONS: Dose adjustments are a strong determinant of whether patients are able to successfully initiate dofetilide. A reinforcement learning algorithm informed by unsupervised learning was able to predict dosing decisions with 96.1% accuracy. Future studies will apply this algorithm prospectively as a data-driven decision aid.
No takes yet. Share an insight, caveat, or question.
Levy et al. (2019) conducted an observational in Patients undergoing dofetilide initiation (n=354). Dose adjustment during dofetilide loading vs. No dose adjustment was evaluated on Successful dofetilide loading (OR 0.19, 95% CI 0.12-0.31, p=<0.001). Dose adjustment during dofetilide loading predicted unsuccessful initiation (OR 0.19; 95% CI 0.12-0.31; p<0.001); a reinforcement learning model predicted dosing decisions with 96.1% accuracy.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: